Praxis Precision Medicines, Inc.
Developing therapies for CNS disorders using insights from genetic epilepsies.
PRAX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74006W2070
- LEI:
- Country:
- United States of America
- Address:
- 99 HIGH STREET, 30TH FLOOR, 2110 BOSTON
- Website:
- https://praxismedicines.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Praxis Precision Medicines is a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) disorders. The company's core strategy involves translating insights from genetic epilepsies to treat conditions characterized by neuronal excitation-inhibition imbalance. Praxis's approach is guided by four principles: focusing on human genetics, utilizing translational tools for validation, applying patient-guided development, and pursuing efficient clinical pathways. Its developmental pipeline includes multiple clinical-stage assets and early-stage programs aimed at delivering treatments for patients with complex brain disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Praxis Precision Medicines, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Praxis Precision Medicines, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Praxis Precision Medicines, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
